Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
Monika D JoshiLeonard TuanquinJunjia ZhuVonn WalterTodd SchellMatthew KaagDeepak KilariJiangang LiaoSheldon L HolderHamid EmamekhooAlexander SankinSuzzane MerrillHong ZhengJoshua WarrickRalph HaukeBenjamin GartrelMark SteinJoseph DrabickDavid J DegraffYousef ZakhariaPublished in: Journal for immunotherapy of cancer (2023)
NCT02891161.